Tag Archives: The New York Times

Senate confirms Gottlieb as FDA chief; former FDA tour, industry ties signal solid choice despite Dems’ jabs

The News: The US Senate voted 57 to 42 on Tuesday (May 9, 2017) to confirm Scott Gottlieb, MD, as Food and Drug Administration (FDA) Commissioner. Gottlieb, who was nominated by… Read more »

Message to GOP on Trumpcare resuscitation effort: it’s dead; get over it

The News: House Speaker Paul Ryan announced a Republican agreement Thursday (April 6, 2017) on legislative language that he said will bring the chamber closer to passing a bill to… Read more »

GOP can’t handle the truth: millions to lose coverage under Trumpcare

Steve’s Take: Remember President Trump’s pre- and post-election promise, no, it sounded more like a guarantee, of “insurance for everybody?” Then last week, the Trump-backed House bill, when finally unveiled… Read more »

Shrouded in secrecy, GOP health plan finally unwrapped; governing crisis now on full display

Steve’s Take: The healthcare goals Pres. Donald Trump articulated in his address last week to a joint session of Congress marked a new record high for policy specifics. But as… Read more »

Trumpcare slowly imploding; perhaps morphing into Obamacare 2.0?

Steve’s Take: Six years after its passage, the Affordable Care Act has demonstrated it’s far from perfect. But replacing such an immense, complicated law on an accelerated schedule is presenting… Read more »

Trump backs negotiating drug prices under Medicare; unless he doesn’t

The News: President Donald Trump supports Medicare drug price negotiations, his spokesman said last week, remarks that sent pharmaceutical stocks swinging again as investors tried to assess whether drugmakers will… Read more »

Trump and pharma execs make nice; what, Sen. Sanders too?

The News: Last week (January 30, 2017), President Trump promised some of the nation’s top drug-company executives in a meeting at the White House that he would shrink Food and… Read more »

FTC opens antitrust investigation of Mylan’s EpiPen dominance; isn’t it high time we live up to Churchill’s rejoinder?

The News: Mylan on Monday (January 30, 2017) acknowledged that the US Federal Trade Commission asked the company “months ago” to provide information about the allergy therapy EpiPen (epinephrine) as… Read more »

Trump’s HHS cabinet pick eludes Congress’s Q&A about Trumpcare specifics; questionable stock investments obscure his suitability to run the US health show

The News: Georgia Rep. Tom Price, President Trump’s choice for secretary of the Department of Health and Human Services, on Tuesday rejected conflict of interest and abuse of power accusations related to… Read more »